Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives

Monoclonal antibodies (mAbs) have been known since the 1970s. However, their therapeutic potential in the medical field has recently emerged, with the advancement of manufacturing techniques. Initially exploited mainly in the oncology field, mAbs have become increasingly relevant in Infectious Disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiros-Roldan, Eugenia, Amadasi, Silvia, Zanella, Isabella, Degli Antoni, Melania, Storti, Samuele, Tiecco, Giorgio, Castelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707981/
https://www.ncbi.nlm.nih.gov/pubmed/34959672
http://dx.doi.org/10.3390/ph14121272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707981/
https://www.ncbi.nlm.nih.gov/pubmed/34959672
http://dx.doi.org/10.3390/ph14121272

Ejemplares similares